ISHIB, along with the scientific co-chairs Michelle A. Albert, MD, MPH and David R. Williams, PhD, MPH, invites you to participate in this annual CME activity. The scientific co-chairs have assembled a multidisciplinary planning committee dedicated to developing a challenging, clinically practical, educational and networking experience. The scientific program will feature plenary sessions, workshops, symposia, and abstracts of new research on cardiovascular disease and other issues of importance to ethnic minority health. The wide range of programming will include findings from the most recent clinical trials, to proven approaches for cardiovascular disease treatment and prevention, to sessions emphasizing behavioral techniques to help patients modify behaviors that affect health.
ISHIB2011 CONFERENCE CO-CHAIRS
Michelle A. Albert, MD, MPH
Brigham and Women's Hospital, Boston, MA
David R. Williams, PhD, MPH
Harvard School of Public Health
Plenary sessions will explore cardiovascular risk factors and their individual and collective impact on the health of ethnic minority populations. Sessions will be conducted in lecture and panel formats where presenters will address ethnic differences, analyze recent clinical trial data, and discuss the theme, "Understanding Cardiovascular Disease Across The Lifespan." The sessions will evaluate the evolving, sometimes controversial, concepts such as true contributors and outcomes, prevalence and treatment, and components and pathophysiology.
Workshops will cover all topics presented in plenary sessions with more in depth information in an interactive, peer-directed, topic-specific format.
Supported symposia will address a variety of topics in 90- to 120-minute meal sessions featuring panel and lecture formats.
At the completion of 2011 programming, participants should be able:
- Evaluate current and emerging medical and community based strategies for providing optimal cardiovascular care to vulnerable populations
- Discuss the impact of Massachusetts Health Care Reform on medical care in Massachusetts particularly as it pertains to high risk populations and national implications
- Review new molecular and genetic data related to risk and treatment of hypertension and other cardiovascular conditions
- Discuss the role of academic medical centers and medical journals in addressing race/ethnic health disparities
- Discuss diabetes and cardiovascular disease risk
- Discuss risk factors for stroke according to race/ethnicity and identify emerging models for hospital based stroke care
- Explore the role of discrimination, stress and the social environment in cardiovascular disease risk
Typical attendees include healthcare providers and advocates concerned with the quality of care and treatment of ethnic patients.
- Medical Researchers
- Public Health Professionals
- Medical Students
- Physician Assistants
- Social Workers
- Pharmaceutical Researchers and Professionals
- Federal and State Health Professionals
- Dietitians and Nutritionists
Should this be more specific to also include, eg: Medical specialists in these areas:
- Internal medicine
- Primary care
CONFERENCE PROMOTION PACKET
Tell your colleagues about ISHIB2011. Included in this area is a packet of information that provides: conference facts, program-at-a-glance, media news advisory, registration forms, and ads of various sizes for use in your newspapers, magazines, or newsletters.
Please consider sending the information packet to your colleagues interested in heart health and sending the ISHIB2011 ads to those in your public affairs office that develop your organization's communication pieces.
Click here to download CONFERENCE PROMOTION PACKET
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the American Society of Hypertension, Inc. and ISHIB. The American Society of Hypertension, Inc. is accredited by the ACCME to provide continuing medical education for physicians.
The American Society of Hypertension, Inc. (ASH) designates this educational activity for a maximum of 19.0 hours AMA Physician's Recognition Award in category 1 credit(s). Physicians should claim only credit commensurate with the extent of their participation in the activity.
CE CREDITS FOR NURSES, DIETITIANS, AND OTHER HEALTHCARE PROFESSIONALS requiring continuing education credits will be provided by ISHIB. ISHIB has been reviewed and approved as an authorized provider by the International Association for Continuing Education and Training (IACET) and uses the criteria and guidelines designated by that organization as the basis for granting continuing education units (CEUs). Participants who successfully complete this activity can receive up to 1.9 CEUs.
CE CREDITS FOR PHARMACISTS will be provided by the National Pharmaceutical Association.
ASH, Inc. strives to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. All presenters in such activities are expected to disclose to the program audience any real or apparent conflict(s) of interest that may have a direct bearing on the subject matter of the session in which they are participating. This pertains to relationships, in place at the time of the activity or in the twelve (12) months preceding the activity, with pharmaceutical companies, biomedical device manufacturers, or other corporations whose products or services are related to the subject matter of the presentation topic. Speakers are also expected to openly disclose any off-label, experimental, or investigational use of drugs or devices in their presentations.